Financial Analyst II
Posted on: 24 Sep 2021
Maple Grove, MN
Job Description
Key Responsibilities:
Build relationships with production unit and manufacturing plant leadership teams.
Assist in all financial planning activities for the Maple Grove Manufacturing Facility, including annual operating plan, quarterly forecasting, and weekly forecast trending.
Analyze spend and variance results, prepare reporting packages, and communicate financial performance.
Perform ad hoc analysis including overhead, product cost, and make vs buy models.
Represent Finance on key initiatives.
Prepare and post journal entries as required for accurate GAAP reporting.
Deliver upon key performance metrics and service levels agreed with business partners.
Perform all responsibilities consistent with our internal control environment and ensures compliance with GAAP and BSC Financial policies and procedures.
Drive continuous improvement of processes and analytics. Document and maintain work instructions.
Basic Requirements:
Bachelor’s degree in Finance or Accounting
2-4 years of relevant experience
Excellent attention to detail and data accuracy
Very strong analytical skills
Strong oral and written communication skills
Must be a quick learner and able to engage well with internal and external customers
Strong Excel and PowerPoint skills required, Financial tools ( SAP, Business Objects) preferred
Quality System Requirements:
In all actions, demonstrates a primary commitment to patient safety and product quality by maintaining compliance to the Quality Policy and all other documented quality processes and procedures.
Boston Scientific
Marlborough, MA
Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
Boston Scientific is primarily known for the development of the Taxus Stent, a drug-eluting stent which is used to open clogged arteries. With the full acquisition of Cameron Health in June 2012, the company also became notable for offering a minimally invasive implantable cardioverter-defibrillator (ICD) which they call the EMBLEM Subcutaneous Implantable Defibrillator (S-ICD)
-
IndustryManufacturing
-
No. of Employees29,000
-
Website
-
Jobs Posted1964
